Repligen Corp (RGEN)
$4.73
0.08 (+1.72%)
| CAPS Rating |
|
|---|---|
| Open | $4.64 |
| Previous Close | $4.65 |
| Daily Range | $4.63 - $4.74 |
| 52-Week Range | $3.41 - $5.85 |
| Market Cap | $145.42M |
| P/E Ratio | 28.53 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 190,173 |
| Average Daily Volume | 80,000 |
RGEN
VS S&P 500 (SPY)
How do you think RGEN will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
RGEN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
RGEN News and Commentary
- 7 Highly Rated Stocks on Sale – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- 7 Reasons Not to Worry This Week – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- 7 Stocks Einstein Would Love – The Motley Fool
- 7 Stocks Shrinking Shares – The Motley Fool
- Buy Low – Blog at The Motley Fool
- Making Cents in Penny Stocks – The Motley Fool
- Repligen Gets a Surprise Infusion of Cash – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- Joining the Fray! – Blog at The Motley Fool
- Get Ready for the Fall – The Motley Fool
- ImClone in a Giving Mood – The Motley Fool
- Making Cents in Penny Stocks – The Motley Fool
- 5 Low-Priced, High-Star Stocks – The Motley Fool
- 5 Top Micro-Cap Stocks – The Motley Fool
Related News and Articles
- This Big Winner Has Hit Its Prime – The Motley Fool
- Dream Stocks for Biotech Investors – The Motley Fool
RSS Headlines
Fool UK
